# The Effect of Spironolactone on Blood Pressure in Type-2 Diabetics With Resistant Hypertension

Study · id `cardio:ct-nct01062763` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01062763](<https://clinicaltrials.gov/study/NCT01062763>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01062763

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 119 participants.

## Technical summary

Registry record NCT01062763. Randomized; quadruple masking; primary purpose treatment. Start 2010-03 (registry gives no type); primary completion 2012-03 (actual). Results posted on 2014-05-08.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 119 participants (enrolled count; ClinicalTrials.gov record NCT01062763, source copy `cardio:ctgov-nct01062763-2014-05-08`, retrieved 2026-10-26)
- Start date: 2010-03 (registry gives no type) (ClinicalTrials.gov record NCT01062763, source copy `cardio:ctgov-nct01062763-2014-05-08`, retrieved 2026-10-26)
- Primary completion: 2012-03 (actual) (ClinicalTrials.gov record NCT01062763, source copy `cardio:ctgov-nct01062763-2014-05-08`, retrieved 2026-10-26)
- Completion: 2012-05 (actual) (ClinicalTrials.gov record NCT01062763, source copy `cardio:ctgov-nct01062763-2014-05-08`, retrieved 2026-10-26)
- Results first posted: 2014-05-08 (ClinicalTrials.gov record NCT01062763, source copy `cardio:ctgov-nct01062763-2014-05-08`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01062763-2014-05-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Effect of Spironolactone on Blood Pressure in Type-2 Diabetics With Resistant Hypertension
- Acronym: SDHDS
- Condition: Arterial Hypertension
- Condition: Hypertension, Resistant to Conventional Therapy
- Condition: Diabetes Mellitus
- Intervention (Drug): spironolactone
- Intervention (Drug): placebo
- Lead sponsor: Ib Abildgaard Jacobsen
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Resistant hypertension (`cardio:resistant-hypertension`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertension (`cardio:pubmed-24739800`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 6def9bfe575837325e2d5325b7c539c28095811c62242af12df173240380f832
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
